Suppr超能文献

恶性疟原虫热休克蛋白90隐秘配体结合位点的研究。

Investigation of a cryptic ligand binding site on Plasmodium falciparum Hsp90.

作者信息

Mansfield Christopher R, Taggart Elizabeth L, Chirgwin Michael E, Derbyshire Emily R

机构信息

Department of Chemistry, Duke University, Durham, NC, USA; Department of Molecular Genetics & Microbiology, Duke Medical School, Durham, NC, USA.

Department of Chemistry, Duke University, Durham, NC, USA.

出版信息

Bioorg Med Chem. 2025 Aug 26;130:118371. doi: 10.1016/j.bmc.2025.118371.

Abstract

The molecular chaperone heat shock protein 90 (Hsp90) has an important role in maintaining proteostasis in Plasmodium parasites, the causative agents of malaria, and is of interest as a potential antimalarial drug target. Inhibitors targeting its well-characterized N-terminal ATP-binding site are lethal, but the development of high-affinity binders with selectivity for the Plasmodium over the human homolog has been challenging given the high conservation of this domain. A binding site in the less conserved Hsp90 C-terminus has been reported to interact with nucleotides and inhibitors in other eukaryotic systems, which could offer an alternative route for antimalarial design. Herein, we characterize the potential ligandability of the C-terminus in the Plasmodium falciparum chaperone PfHsp90 with in silico and in vitro methods. We conducted affinity experiments with both a lysine-reactive nucleotide analog and an ATP resin that support a specific interaction between ATP and a C-terminal truncation of PfHsp90. We further explored the nucleotide structural requirements for this interaction with limited proteolysis experiments, which suggest association with ATP, dATP, and ADP, but not AMP or GTP. Lastly, we employed computational analyses and mutagenesis studies to interrogate the molecular basis for the interaction. Our findings provide the foundation for future studies to assess and develop C-terminal Hsp90 inhibitors against Plasmodium parasites.

摘要

分子伴侣热休克蛋白90(Hsp90)在维持疟原虫(疟疾的病原体)的蛋白质稳态中起着重要作用,并且作为潜在的抗疟药物靶点备受关注。靶向其特征明确的N端ATP结合位点的抑制剂具有致死性,但鉴于该结构域的高度保守性,开发对疟原虫比对人类同源物具有选择性的高亲和力结合剂一直具有挑战性。据报道,在其他真核生物系统中,保守性较低的Hsp90 C端的一个结合位点可与核苷酸和抑制剂相互作用,这可能为抗疟药物设计提供一条替代途径。在此,我们用计算机模拟和体外方法表征了恶性疟原虫伴侣蛋白PfHsp90 C端的潜在可配体性。我们用赖氨酸反应性核苷酸类似物和ATP树脂进行了亲和力实验,这些实验支持ATP与PfHsp90 C端截短体之间的特异性相互作用。我们通过有限蛋白酶解实验进一步探索了这种相互作用的核苷酸结构要求,实验结果表明其与ATP、dATP和ADP相关,但与AMP或GTP无关。最后,我们采用计算分析和诱变研究来探究这种相互作用的分子基础。我们的研究结果为未来评估和开发针对疟原虫的C端Hsp90抑制剂的研究奠定了基础。

相似文献

1
Investigation of a cryptic ligand binding site on Plasmodium falciparum Hsp90.
Bioorg Med Chem. 2025 Aug 26;130:118371. doi: 10.1016/j.bmc.2025.118371.
3
Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission.
Cochrane Database Syst Rev. 2014 Jun 30(6):CD008152. doi: 10.1002/14651858.CD008152.pub3.
4
Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission.
Cochrane Database Syst Rev. 2015 Feb 19(2):CD008152. doi: 10.1002/14651858.CD008152.pub4.
6
Heat shock protein 90 chaperone activity is required for hepatitis A virus replication.
J Virol. 2025 Jul 22;99(7):e0050225. doi: 10.1128/jvi.00502-25. Epub 2025 Jun 5.
7
Primaquine for reducing Plasmodium falciparum transmission.
Cochrane Database Syst Rev. 2012 Sep 12(9):CD008152. doi: 10.1002/14651858.CD008152.pub2.
8
Changes in susceptibility of to antimalarial drugs in Uganda over time: 2019-2024.
medRxiv. 2025 Jan 1:2024.12.31.24319821. doi: 10.1101/2024.12.31.24319821.
10
An expanded method for malaria parasite genetic surveillance using targeted nanopore sequencing.
Gates Open Res. 2025 Jul 24;9:49. doi: 10.12688/gatesopenres.16355.1. eCollection 2025.

本文引用的文献

1
Structural Insights into Selectively Targeting Hsp90.
Biochemistry. 2025 Jun 3;64(11):2401-2411. doi: 10.1021/acs.biochem.5c00015. Epub 2025 May 21.
2
The known unknowns of the Hsp90 chaperone.
Elife. 2024 Dec 31;13:e102666. doi: 10.7554/eLife.102666.
3
An update on the status of HSP90 inhibitors in cancer clinical trials.
Cell Stress Chaperones. 2024 Aug;29(4):519-539. doi: 10.1016/j.cstres.2024.05.005. Epub 2024 Jun 13.
4
Accurate structure prediction of biomolecular interactions with AlphaFold 3.
Nature. 2024 Jun;630(8016):493-500. doi: 10.1038/s41586-024-07487-w. Epub 2024 May 8.
5
Plasmodium falciparum heat shock proteins as antimalarial drug targets: An update.
Cell Stress Chaperones. 2024 Apr;29(2):326-337. doi: 10.1016/j.cstres.2024.03.007. Epub 2024 Mar 20.
6
Development of Hsp90 C-terminal inhibitors with noviomimetics that manifest anti-proliferative activities.
RSC Med Chem. 2024 Jan 18;15(3):888-894. doi: 10.1039/d3md00529a. eCollection 2024 Mar 20.
7
Selective targeting of Plasmodium falciparum Hsp90 disrupts the 26S proteasome.
Cell Chem Biol. 2024 Apr 18;31(4):729-742.e13. doi: 10.1016/j.chembiol.2024.02.008. Epub 2024 Mar 15.
8
Antimalarial drug discovery: progress and approaches.
Nat Rev Drug Discov. 2023 Oct;22(10):807-826. doi: 10.1038/s41573-023-00772-9. Epub 2023 Aug 31.
9
Target Deconvolution by Limited Proteolysis Coupled to Mass Spectrometry.
Methods Mol Biol. 2023;2706:177-190. doi: 10.1007/978-1-0716-3397-7_13.
10
Structural and functional complexity of HSP90 in cellular homeostasis and disease.
Nat Rev Mol Cell Biol. 2023 Nov;24(11):797-815. doi: 10.1038/s41580-023-00640-9. Epub 2023 Jul 31.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验